GlassScriptPhysician profile
Jonathan David Grossman
NPI 1225242332
$403,712.72
in general payments reported to CMS, 2019-2025
25 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $51K · 2021: $32K · 2022: $49K · 2023: $75K · 2024: $93K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Consulting Fee: $55K · Travel and Lodging: $39K · Royalty Or License: $31K · Food and Beverage: $17K · Education: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,070.00 |
| Consulting Fee | $54,910.00 |
| Travel and Lodging | $39,191.42 |
| Royalty Or License | $31,051.83 |
| Food and Beverage | $17,463.16 |
| Education | $14,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgentec | $155,522.54 | 2021-2025 | Tilink, Ion, Ion Facet Screw System |
| Medtronic, INC. | $111,021.51 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Surgalign Spine Technologies, INC. | $44,929.33 | 2019-2020 | |
| Medtronic USA, INC. | $43,426.13 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $26,583.51 | 2020-2022 | |
| Abbott Laboratories | $10,929.15 | 2019-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $2,998.75 | 2025 | Senza, Vyrsa V1, Omnia |
| Nevro Corp. | $1,925.76 | 2019-2024 | Senza |
| Orthofundamentals, LLC | $1,500.00 | 2025 | Trellis Si Joint Fusion System |
| Biotronik Nro, INC. | $1,474.87 | 2023-2025 | Prospera, Biotronik |
| Omnia Medical, LLC | $1,000.00 | 2020 | |
| Mml US, INC. | $647.36 | 2025 | Reactiv8 |
| Boston Scientific Corporation | $514.21 | 2019-2023 | |
| Spr Therapeutics, INC | $404.04 | 2022-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $187.20 | 2023 | Intracept |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $133.95 | 2023 | |
| Nalu Medical, INC. | $118.10 | 2024-2025 | Nalu Neurostimulation System |
| Spinefrontier, INC. | $81.96 | 2024 | Nanofuse, Inspan |
| Spinal Simplicity, LLC | $65.43 | 2019 | |
| Vertiflex, INC. | $61.91 | 2019 | |
| Vertos Medical, INC. | $58.43 | 2020-2024 | Mild Device Kit |
| Zimmer Biomet Holdings, INC. | $48.11 | 2020 | |
| Curonix LLC | $33.37 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $33.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.